Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg
Code effective Jul 01, 2024
HCPCS Section
Drugs administered other than oral method, chemotherapy drugs
J0687 is a valid 2026 HCPCS code meaning Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg or (Inj cefazolin (wg crit care)) for short. HCPCS J0687 has been effective since 07/01/2024 and applies to Medical care.
|
HCPCS Level II Code Section J - Drugs administered other than oral method, chemotherapy drugs |
|
| HCPCS Code | J0687 |
|---|---|
| Description |
Long description:
Short description: |
| HCPCS Pricing indicator |
51 - Drugs
|
| Multiple pricing indicator |
A - Not applicable as HCPCS priced under one methodology
|
| Coverage code | D - Special coverage instructions apply |
| ASC payment group code | Effective Jul 01, 2024 - This procedure is approved to be performed in an ambulatory surgical center. |
| BETOS2 code | O1E - Other drugs |
| HCPCS Action code | N - No maintenance for this code |
| Type of service | 1 - Medical care |
| Effective date | Effective Jul 01, 2024 |
| Date added | Added Jul 01, 2024 |
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/24/2026
CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.